levodopa has been researched along with fenoldopam in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthelmebs, M; Froehly, S; Grima, M; Imbs, JL; Stephan, D; Vailly, B; Velly, J | 1 |
| Casagrande, C; La Regina, A; Merlo, L | 1 |
| Carey, RA; Jacob, L | 1 |
| Hasenfuss, G; Just, H | 1 |
| Goldberg, LI; Rajfer, SI | 1 |
| Goldberg, LI | 1 |
| Dawson, R; Felheim, R; Phillips, MI | 1 |
| Barthelmebs, M; Grima, M; Imbs, JL; Mayer, P; Thomas, A | 1 |
| Miranda, HF; Pinardi, G; Prieto, JC; Quevedo, M | 2 |
| Moreira-Rodrigues, M; Pestana, M; Sampaio-Maia, B; Serrão, P | 1 |
4 review(s) available for levodopa and fenoldopam
| Article | Year |
|---|---|
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
Topics: Animals; Benzazepines; Blood Pressure; Bromocriptine; Domperidone; Dopamine; Ergolines; Fenoldopam; Humans; Hypertension; Levodopa; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasoconstriction; Vasodilation | 1984 |
7 other study(ies) available for levodopa and fenoldopam
| Article | Year |
|---|---|
Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Carbidopa; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Hemodynamics; Levodopa; Male; Prodrugs; Rats; Rats, Inbred Strains; Streptozocin | 1991 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance | 1985 |
Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Cell Line; Chlorpromazine; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine Antagonists; Epithelial Cells; Epithelium; Ergolines; Fenoldopam; Kidney; Levodopa; Phenothiazines; Quinpirole; Trifluoperazine | 1993 |
Pathophysiological role of dopamine in the kidney: effects in diabetes mellitus and after contralateral nephrectomy.
Topics: Adaptation, Physiological; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fenoldopam; Kidney; Levodopa; Nephrectomy; Prodrugs; Rats; Rats, Wistar | 1995 |
Isobolographic analysis of the interaction between fenoldopam and levodopa on arterial blood pressure of the rat.
Topics: Animals; Antihypertensive Agents; Antiparkinson Agents; Blood Pressure; Drug Synergism; Fenoldopam; Levodopa; Rats; Rats, Sprague-Dawley | 2000 |
Hypotensive effect of dopamine: synergism induced by fenoldopam or levodopa.
Topics: Animals; Blood Pressure; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Fenoldopam; Levodopa; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2005 |
Blunted renal dopaminergic system activity in HgCl2-induced membranous nephropathy.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Dopamine Agonists; Fenoldopam; Glomerulonephritis, Membranous; Kidney; Kidney Cortex; Kidney Tubules, Proximal; Levodopa; Male; Mercuric Chloride; Proteinuria; Rats; Rats, Inbred BN; Sodium; Sodium-Potassium-Exchanging ATPase | 2006 |